GFAP and Parkinson disease: Of note, these results are consistent with previous clinical findings that showed a rise in pro-inflammatory cytokine levels, including TNF and IL-1β, and signs of glial cell activation (i.e., an increase in ganglionic GFAP levels) in colonic biopsies from patients with PD [90].